THC — Tenet Healthcare Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $283.33
- YTD price return
- +42.58%
- YTD total return
- +42.58%
- Market cap
- 22.5B
- Enterprise value
- 36.8B
- Shares outstanding
- 79.6M
- 52W low
- $157.58
- 52W high
- $301.44
- From 52W high
- -6.01%
- From 52W low
- +79.80%
- 52W range
- 87%$158–$301
- Beta
- 1.22
Volume
- Rel volume
- 0.83×
- 30D volume
- 763.9K
- 30D $ vol
- 206.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$40.5M
- Insider net 1Y
- −$62.5M
Form 4 transactions by trade date, as filed; latest on file 2026-09-14.
Fundamentals
- Sales (ttm)
- 22.2B
- Sales/share
- $278.36
- EPS (ttm)
- $34.10
- FCF (ttm)
- 3.3B
- FCF/share
- $41.82
- Book value/share
- $68.40
- Net margin
- 13.09%
- ROE
- 53.25%
- ROA
- 9.18%
- Debt / equity
- 2.40×
- Current ratio
- 1.58
Growth (CAGR, ttm) · 10Y
- Sales
- +6.23%+3.19%+2.54%+1.25%
- Net income
- +114.22%+83.50%+21.86%n/a
- FCF
- +121.69%+42.99%+23.96%+36.16%
- Shares
- -9.45%-7.80%-5.77%-2.22%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +133.96%+96.93%+27.83%n/a
- Sales/share
- +17.31%+11.93%+8.82%+3.63%
- FCF/share
- +144.82%+55.09%+31.56%+39.25%
- Book value/share
- +49.81%+68.02%+58.97%+29.15%
- Price
- +38.79%+73.10%+30.29%+31.90%
- Total return
- +38.79%+73.10%+30.29%+31.90%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 8.3×
- P/OI (ttm)
- 4.2×
- Fwd P/E
- 14.0×
- P/S (ttm)
- 1.0×
- P/B (mrq)
- 4.1×
- P/FCF (ttm)
- 6.8×
- EV/EBITDA (fy)
- 5.8×
- EV/Sales (ttm)
- 1.7×
- FCF yield (ttm)
- 14.76%
- Buyback yield (realized, 1y)
- 9.45%
- Shareholder yield (realized, 1y)
- 9.45%
- Buyback yield (cash, ttm)
- 8.04%
- Shareholder yield (cash, ttm)
- 8.04%
Vs own 10Y history
- P/E
- 28th
- P/OI
- 89th
- P/S
- 100th
- P/B
- 35th
- P/FCF
- 47th
Bar = where today’s multiple sits in THC’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +12.0%10Y CAGR +12.5%YoY +96.9%EPS (diluted)
5Y CAGR +32.8%10Y n/mYoY +221.5%Free cash flow
5Y CAGR −2.5%10Y CAGR +30.0%YoY +39.2%TTM: operating cash flow $4.2B, capex −$910M
Q3 2026: operating cash flow $1.3B, capex −$198M
Shares (diluted)
5Y −14.5%10Y −8.4%YoY −9.0%Net income
5Y CAGR +28.7%10Y n/mYoY +192.4%About Tenet Healthcare#
Data provided bySource: Twelve DataTenet Healthcare Corp. is a diversified healthcare services company focused on delivering hospital care, outpatient treatment, and related support services across the United States. The company operates acute care and specialty hospitals, ambulatory surgery centers, and a broad network of outpatient facilities that provide services such as emergency care, diagnostics, radiology, respiratory therapy, clinical laboratories, and pharmacies. Its business also includes physician services and revenue cycle management through Conifer Health Solutions, which supports hospitals, health systems, physician practices, and employers with administrative and financial operations. Through this combination of inpatient care, ambulatory surgery, and healthcare services infrastructure, Tenet Healthcare Corp. plays an important role in providing coordinated care delivery across multiple settings and patient needs. The company is headquartered in Dallas, Texas.
Dallas, TX·77,000 employees·Medical Care Facilities·tenethealth.com·As of Oct 28, 2026
Recent filings#
- Oct 29Earnings · Earnings release — EPS $6.64 vs $4.60 est. (+44.4%); revenue $5.63B (+6% y/y) 0.8%
- Sep 14Insider sale · KERREY J ROBERT (Director) sold 12,010 shares for $3.2M at $263.04–$264.62
- Sep 10Insider sale · MARK RICHARD J (Director) sold 10,000 shares for $2.6M at $263.42
- Sep 88-K · Tenet Announces Private Offering of Senior Notes to Refinance $1.5 Billion in Outstanding Notes
- Sep 2Insider sale · West Nadja (Director) sold 1,152 shares for $298K at $258.80
ETFs holding THC#
19 of the 193 ETFs ChartRow carries live hold THC. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | 0.4% |
| MDY | SPDR S&P MidCap 400 ETF Trust | 0.4% |
| VBR | Vanguard Small-Cap Value ETF | 0.3% |
| VHT | Vanguard Health Care ETF | 0.3% |
| VB | Vanguard Small-Cap ETF | 0.2% |
| VXF | Vanguard Extended Market ETF | 0.2% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.2% |
| IWR | iShares Russell Midcap ETF | 0.1% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
